Clopidogrel Hydrogen Sulfate is a thienopyridine. Its actions make it an important antiplatelet agent alone. It is used in those patients who have at least one risk factor for vascular events such as a heart attack or stroke, cannot take other medicines that prevent blood clots, and are at low risk of bleeding. Clopidogrel Hydrogen Sulfate is also used with acetylsalicylic acid in the prevention of cardiovascular complications. These include myocardial infarction, ischaemic stroke, a stroke caused by failure of the blood supply to part of the brain, and peripheral arterial disease, in which there are problems with blood flow in the arteries, a condition known as ‘acute coronary syndrome’, where it is administered with aspirin to prevents blood clots. An acute coronary syndrome is a group of cardiovascular complications including heart attacks and a severe type of chest pain called unstable angina. It is also used to treat irregular rapid contractions of the upper chambers of the heart, in combination with aspirin. Sanofi SA filed the first patented in 1982 in France, in the USA, Bristol-Myers Squibb Company file for patents in1990. The FDA approved Clopidogrel Bisulphate in 1998. Due to its widespread use and safety the World Health Organization's has put it on their list of Essential Medicines.

Clopidogrel Hydrogen Sulfate is available as tablets. The recommended adult dose is one 75-mg tablet, taken once a day. In acute coronary syndrome, the recommended initial loading dose is one 300-mg. this is followed by a secondary dose set at 75-mg dose, taken once a day for at least four weeks. For treating ‘ST-segment-elevation’ myocardial infarction or for up to 12 months. In the treatment of acute coronary syndrome and atrial fibrillation, it is used together with aspirin at a dose no higher than 100 mg. In some patients with genetic complications, this medication does not get absorbed fully reducing its efficiency.

The active substance of this medicine, Clopidogrel inhibits platelet aggregation resulting in the formation of blood clots. Blood clots are formed by special cells in the blood called platelets sticking together. Its actions prevent the platelets from aggregating by blocking a substance called ADP from attaching to a special receptor on their surface. The resulting action is the prevention of the platelets becoming ‘sticky’. As they become less sticky, it reduces the risk of a blood clot forming eventually leading to the prevention of another heart attack or stroke kind of event in the future.

In the USA, the cost of a monthly dose for 10 mg tablet is around $207. This medicine is not sold widely. On the Pipelinepharma marketplace, you can easily browse a complete list of Clopidogrel Hydrogen Sulfate offers for B2B purchase, with communication facilitated through the online interface. This allows for a quick and hassle-free sourcing experience, without having to check multiple separate sites for listings. Clopidogrel Hydrogen Sulfate is available for sale from a variety of Clopidogrel Hydrogen Sulfate vendors at a range of costs.

The process of finding trusted Clopidogrel hydrogen sulfate manufacturers and Clopidogrel hydrogen sulfate suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Clopidogrel hydrogen sulfate. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Clopidogrel Hydrogen Sulfate offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Clopidogrel Hydrogen Sulfate manufacturers and Clopidogrel Hydrogen Sulfate suppliers that you are looking for. These also enable you to check the dossier status of Clopidogrel Hydrogen Sulfate, and the GMP approvals of the different variants of Clopidogrel Hydrogen Sulfate. Also, each manufacturer or supplier product description contains essential information about Clopidogrel Hydrogen Sulfate including clinical data, stability zones, countries where Clopidogrel Hydrogen Sulfate is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Clopidogrel Hydrogen Sulfate offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than the Good Manufacturing Practice approvals that Clopidogrel Hydrogen Sulfate manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Clopidogrel Hydrogen Sulfate manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.